Fujian Wanchen Biotechnology Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 53.72% vs 124.02% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 149.43% vs 461.51% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16,634.40",
          "val2": "10,820.90",
          "chgp": "53.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,181.70",
          "val2": "602.40",
          "chgp": "96.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "20.40",
          "val2": "17.20",
          "chgp": "18.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "967.80",
          "val2": "388.00",
          "chgp": "149.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "71.00%",
          "val2": "48.70%",
          "chgp": "2.23%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 59.08% vs 247.83% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 301.77% vs 513.22% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "51,378.80",
          "val2": "32,296.50",
          "chgp": "59.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,430.20",
          "val2": "1,263.80",
          "chgp": "171.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "55.30",
          "val2": "53.30",
          "chgp": "3.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,423.90",
          "val2": "603.30",
          "chgp": "301.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "61.30%",
          "val2": "30.40%",
          "chgp": "3.09%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

16,634.40

10,820.90

53.72%

Operating Profit (PBDIT) excl Other Income

1,181.70

602.40

96.17%

Interest

20.40

17.20

18.60%

Exceptional Items

0.00

0.00

Consolidate Net Profit

967.80

388.00

149.43%

Operating Profit Margin (Excl OI)

71.00%

48.70%

2.23%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 53.72% vs 124.02% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 149.43% vs 461.51% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

51,378.80

32,296.50

59.08%

Operating Profit (PBDIT) excl Other Income

3,430.20

1,263.80

171.42%

Interest

55.30

53.30

3.75%

Exceptional Items

-10.70

0.00

Consolidate Net Profit

2,423.90

603.30

301.77%

Operating Profit Margin (Excl OI)

61.30%

30.40%

3.09%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 59.08% vs 247.83% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 301.77% vs 513.22% in Dec 2024

All Annual Results